SEC Form SCHEDULE 13G filed by Collegium Pharmaceutical Inc.
$COLL
Biotechnology: Pharmaceutical Preparations
Health Care
|
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 |
SCHEDULE 13G
|
UNDER THE SECURITIES EXCHANGE ACT OF 1934
|
COLLEGIUM PHARMACEUTICAL, INC (Name of Issuer) |
Common Stock, Par Value $0.001 Per Share (Title of Class of Securities) |
19459J104 (CUSIP Number) |
12/31/2024 (Date of Event Which Requires Filing of this Statement) |
| Check the appropriate box to designate the rule pursuant to which this Schedule is filed: |
 Rule 13d-1(b)
|
 Rule 13d-1(c)
|
| Rule 13d-1(d)
|
SCHEDULE 13G
|
| CUSIP No. | 19459J104 |
| 1 | Names of Reporting Persons
Pacer US Small Cap Cash Cows ETF | ||||||||
| 2 | Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
| ||||||||
| 3 | Sec Use Only | ||||||||
| 4 | Citizenship or Place of Organization
DELAWARE
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 9 | Aggregate Amount Beneficially Owned by Each Reporting Person
2,138,828.00 | ||||||||
| 10 | Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
| ||||||||
| 11 | Percent of class represented by amount in row (9)
5.39 % | ||||||||
| 12 | Type of Reporting Person (See Instructions)
IV |
SCHEDULE 13G
|
| CUSIP No. | 19459J104 |
| 1 | Names of Reporting Persons
Pacer US Small Cap Cash Cows Growth Leaders ETF | ||||||||
| 2 | Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
| ||||||||
| 3 | Sec Use Only | ||||||||
| 4 | Citizenship or Place of Organization
DELAWARE
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 9 | Aggregate Amount Beneficially Owned by Each Reporting Person
3,663.00 | ||||||||
| 10 | Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
| ||||||||
| 11 | Percent of class represented by amount in row (9)
0.01 % | ||||||||
| 12 | Type of Reporting Person (See Instructions)
IV |
SCHEDULE 13G
|
| CUSIP No. | 19459J104 |
| 1 | Names of Reporting Persons
Pacer Advisors, Inc. | ||||||||
| 2 | Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
| ||||||||
| 3 | Sec Use Only | ||||||||
| 4 | Citizenship or Place of Organization
PENNSYLVANIA
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 9 | Aggregate Amount Beneficially Owned by Each Reporting Person
2,142,491.00 | ||||||||
| 10 | Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
| ||||||||
| 11 | Percent of class represented by amount in row (9)
5.4 % | ||||||||
| 12 | Type of Reporting Person (See Instructions)
IA |
SCHEDULE 13G
|
| CUSIP No. | 19459J104 |
| 1 | Names of Reporting Persons
Joe M. Thomson | ||||||||
| 2 | Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
| ||||||||
| 3 | Sec Use Only | ||||||||
| 4 | Citizenship or Place of Organization
UNITED STATES
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 9 | Aggregate Amount Beneficially Owned by Each Reporting Person
2,142,491.00 | ||||||||
| 10 | Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
| ||||||||
| 11 | Percent of class represented by amount in row (9)
5.4 % | ||||||||
| 12 | Type of Reporting Person (See Instructions)
IN |
SCHEDULE 13G
|
| Item 1. | ||
| (a) | Name of issuer:
COLLEGIUM PHARMACEUTICAL, INC | |
| (b) | Address of issuer's principal executive offices:
100 Technology Center Drive, Stoughton, Massachusetts, 02072 | |
| Item 2. | ||
| (a) | Name of person filing:
This statement is filed by Pacer US Small Cap Cash Cows ETF and Pacer US Small Cap Cash Cows Growth Leaders ETF, each a series of Pacer Funds Trust, a Delaware statutory trust (together, the Funds), Pacer Advisors, Inc., a Pennsylvania corporation (the Adviser), and Joe M. Thomson (Mr. Thomson) (Mr. Thomson together with the Funds and the Adviser, collectively, the Reporting Persons and each a Reporting Person), with respect to shares of common stock, par value $0.001 per share (Common Stock), of Collegium Pharmaceutical, Inc., a Virginia corporation (the Issuer).
The Reporting Persons have entered into a Joint Filing Agreement, a copy of which is filed May 2, 2025 with this Schedule 13G as Exhibit 99.2, pursuant to which they have agreed to file this Schedule 13G jointly in accordance with the provisions of Rule 13d-1(k) of the Act. | |
| (b) | Address or principal business office or, if none, residence:
The address of the principal business office of each of the Reporting Persons is 500 Chesterfield Parkway Malvern, Pennsylvania 19355. | |
| (c) | Citizenship:
The Funds are series in a Delaware statutory trust, the Adviser is a Pennsylvania corporation, and Mr. Thomson is a United States citizen. | |
| (d) | Title of class of securities:
Common Stock, Par Value $0.001 Per Share | |
| (e) | CUSIP No.:
19459J104 | |
| Item 3. | If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: | |
| (a) | Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
| |
| (b) | Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
| |
| (c) | Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
| |
| (d) | Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
| |
| (e) | An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
| |
| (f) | An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
| |
| (g) | A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
| |
| (h) | A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
| |
| (i) | A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
| |
| (j) | A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution: | |
| (k) | Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
| |
| Item 4. | Ownership | |
| (a) | Amount beneficially owned:
The Funds are registered under the Investment Company Act of 1940, as amended, and own directly 2,142,491 shares of Common Stock. The Adviser is registered under the Investment Advisers Act of 1940, as amended, and serves as the investment adviser to the Funds. Pursuant to the investment advisory agreement with the Funds, the Adviser maintains discretionary investment and voting authority with respect to 2,142,491 shares of Common Stock held by the Funds. Mr. Thomson is the majority stockholder of the Adviser and may be deemed to be the beneficial owner of the shares of Common Stock held by the Funds. Each of the Adviser and Mr. Thomson disclaims beneficial ownership of the shares of Common Stock held by the Funds. The percentages used herein are calculated upon 39,646,749 shares of common stock issued and outstanding as of December 31, 2024, pursuant to information supplied by the Issuer. | |
| (b) | Percent of class:
Fund: 5.40%; Adviser: 5.40%; Mr. Thomson: 5.40% | |
| (c) | Number of shares as to which the person has:
| |
| (i) Sole power to vote or to direct the vote:
Fund: 0; Adviser: 0; Mr. Thomson: 0 | ||
| (ii) Shared power to vote or to direct the vote:
Fund: 2,142,491; Adviser: 2,142,491; Mr. Thomson: 2,142,491 | ||
| (iii) Sole power to dispose or to direct the disposition of:
Fund: 0; Adviser: 0; Mr. Thomson: 0 | ||
| (iv) Shared power to dispose or to direct the disposition of:
Fund: 2,142,491; Adviser: 2,142,491; Mr. Thomson: 2,142,491 | ||
| Item 5. | Ownership of 5 Percent or Less of a Class. | |
| Item 6. | Ownership of more than 5 Percent on Behalf of Another Person. | |
Not Applicable
| ||
| Item 7. | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. | |
Not Applicable
| ||
| Item 8. | Identification and Classification of Members of the Group. | |
Not Applicable
| ||
| Item 9. | Notice of Dissolution of Group. | |
Not Applicable
| ||
| Item 10. | Certifications: |
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. |
| SIGNATURE | |
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
|
|
|
|
|
|
|
|
Exhibit Information
|
Joint Agreement |